All articles tagged with #procter and gamble
Procter & Gamble and Colgate have reformulated their dental floss products to remove PTFE and PFAS, citing health concerns and state regulations. A 2019 study linked Oral-B Glide use to higher levels of a specific forever chemical in blood, prompting industry-wide changes to safer, non-fluorinated materials.
Five US companies with over 50 years of consecutive dividend increases are highlighted as stable income sources for retirees. Procter & Gamble and Johnson & Johnson lead with long payout histories and strong cash flow, while Lowe’s, Emerson Electric, and Genuine Parts offer varying yields and growth profiles. Each company’s dividend is backed by free cash flow rather than debt, providing resilience against economic shocks. Risks include commodity costs, litigation, and corporate splits, but overall, these stocks aim to deliver reliable returns with low volatility.
Procter & Gamble is buying supplement brand Thorne for $3.8 billion to accelerate growth of its health and wellness division. The deal follows Thorne’s long-running presence since 1984, its private-equity ownership in 2023, and more than $500 million in revenue in 2025, with the company expanding direct-to-consumer sales. P&G CEO Shailesh Jejurikar described Thorne as a well-run asset with potential to become a billion-dollar brand, as the acquisition moves toward formal announcement.
A retirement-focused article argues for a three-pronged dividend strategy: Procter & Gamble as a wealth-preservation anchor with a long dividend-raising history, Enterprise Products Partners offering a high, fee-based 5.7% yield and solid coverage, and Ares Capital providing a double-digit yield as a BDC. Together they aim to deliver durable income for decades, though each carries caveats: PG faces commodity-cost headwinds, EPD involves a K-1 tax form and leverage risk, and ARCC is sensitive to credit cycles and non-accruals.
P&G posted a mixed Q4 2026: adjusted EPS of $1.43 beat expectations, while revenue of $21.2 billion missed consensus amid flat organic growth and generally slowing demand. Beauty led with 3% volume growth; other segments were weaker, and health care was the softest. For fiscal 2027, the company sees EPS of $6.89–$7.11 and 1%–3% sales growth, but faces roughly $1 billion in after‑tax headwinds from higher costs. CEO Shailesh Jejurikar will become chair of the board on August 1.
With the Dow marking its 130th anniversary, The Motley Fool spotlights Nvidia, Visa, and Procter & Gamble as top blue-chip dividend picks for June, noting Nvidia’s massive dividend hike to $1 per share (about 0.5% yield) amid AI-driven growth, Visa’s strong cash flow and buybacks supporting durable returns, and P&G’s long track record of annual dividend increases and a solid 3% yield for reliable income.
Procter & Gamble beat adjusted EPS estimates for Q2 2026 at $1.88, but revenue of $22.21 billion came in modestly below the $22.28 billion consensus. Net income was $4.32 billion ($1.78 per share) versus $4.63 billion ($1.88) a year earlier; excluding items, EPS was $1.88. Net sales rose 1%. Demand for Gillette razors and Pampers diapers weakened, and the stock slipped about 2% in premarket trading.
Jim Cramer recommends buying Procter & Gamble stock, citing its effective use of AI to improve operations and its attractive valuation, while expressing caution on high-spending tech giants like Nvidia and Apple due to uncertain growth prospects.
Procter & Gamble reported better-than-expected quarterly results driven by continued consumer demand for beauty and hair-care products despite a broader economic slowdown, with strategic price hikes and product innovations helping offset higher tariffs and competitive discounting. The company also announced cost-cutting measures and market exits to adapt to challenging global conditions.
Procter & Gamble beat earnings estimates with higher demand in beauty and grooming, but warned of increased costs from tariffs in 2026, maintaining its full-year outlook despite a challenging environment.
Procter & Gamble plans to raise prices on 25% of its products in the US starting August to offset $1 billion in tariff-related costs, amid economic uncertainty and slowing growth, while also restructuring and appointing a new CEO. Despite these challenges, the company reported solid earnings, though growth is expected to slow in fiscal 2026.
Procter & Gamble beat quarterly earnings estimates but warned that tariffs and other costs will negatively impact its fiscal 2026 earnings, with expected sales growth of 1-5% and earnings per share of $6.83 to $7.09, reflecting a $1 billion hit from tariffs and other factors.
Procter & Gamble CEO Jon Moeller is stepping down after four years to become executive chairman, with COO Shailesh Jejurikar set to succeed him as CEO starting January 2026, in a planned leadership transition.
Procter & Gamble announced that Shailesh Jejurikar will become CEO in 2026, succeeding Jon Moeller who will become executive chairman. Jejurikar, the first Asian to lead P&G, has been with the company since 1989 and is currently COO. This leadership change follows recent restructuring and job cuts amid slowing sales, with Jejurikar also standing for election to the company's board.
Procter & Gamble announced it will cut 7,000 non-manufacturing jobs, about 15% of that workforce, over the next two years due to tariffs implemented by President Trump, and will also reduce product offerings in certain markets, aiming to maintain growth and value creation despite economic challenges.